Protocol detail

Glioma Cell Line Transfection and Transduction

Protocol full text hidden due to copyright restrictions

However, the full text is available at the following link: Access Free Full Text.

Fan Q., Aksoy O., Wong R.A., Ilkhanizadeh S., Novotny C.J., Gustafson W.C., Truong A.Y., Cavanan G., Simonds E.F., Haas-Kogan D., Phillips J.J., Nicolaides T., Okaniwa M., Shokat K.M, & Weiss W.A. (2017). A Kinase Inhibitor Targeted to mTORC1 Drives Regression in Glioblastoma. Cancer cell, 31(3), 424-435.

Publication 2017

Effectene-transfection reagent Rapamycin NVP-BEZ235 MLN0128 MK-2206 KU-0063794 FK-506 Insulin

Akt inhibitor viii As252424 As605240 Cell line Cells Effectene Egfr Egfrviii Fk 506 G418 Gdc 0941 Glioma Gold Human Hygromycin Ic87114 Inhibitors Insulin Ku 0063794 Luciferin Mk 2206 Mln0128 Nvp bez235 Plasmid Rapalink 1 Rapamycin Retrovirus Transfection Virus

Corresponding Organization : Neurological Surgery

Other organizations : Howard Hughes Medical Institute, Dana-Farber Cancer Institute

Top 5 similar protocols

Variable analysis

Dependent Variables detection not available due to copyright restrictions.
Unable to provide accurate variables.

Annotations

Annotations not available due to copyright restrictions

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!